INTERNATIONAL PATENT: WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY, 武汉人福创新药物研发中心有限公司 FILES APPLICATION FOR "DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF"

Posted On: 2025-06-23

GENEVA, June 23 -- WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY (Room 705-2, Building C7, No.666 Gaoxin Road, Wuhan East Lake High-tech Development ZoneWuhan, Hubei 430075), 武汉人福创新药物研发中心有限公司 (中国湖北省武汉市东湖新技术开发区高新大道666号C7栋705-2室) filed a patent application (PCT/CN2024/139216) for "DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF" on Dec 13, 2024. With publication no. WO/2025/124557, the details related to the patent...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY, 武汉人福创新药物研发中心有限公司 FILES APPLICATION FOR "DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF"